oxidopamine has been researched along with Weight Loss in 6 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Weight loss is due primarily to reduced energy intake and increased energy expenditure." | 1.46 | Brown adipose tissue activation in a rat model of Parkinson's disease. ( An, J; Fang, D; Gao, Y; Lu, T; Meng, X; Ruan, HB; Wang, L; Wang, W; Wang, X; Yang, C; Zhang, J, 2017) |
| "Cimetidine was without effect on wet-dog shakes, burrowing, and body weight loss." | 1.29 | The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice. ( el Kadi, AO; Sharif, SI, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Stefanidis, A | 1 |
| Lee, CMC | 1 |
| Greaves, E | 1 |
| Montgomery, MK | 1 |
| Arnold, M | 1 |
| Newn, S | 1 |
| Budin, AJ | 1 |
| Lemus, MB | 1 |
| Foldi, CJ | 1 |
| Burton, PR | 1 |
| Brown, WA | 1 |
| Lutz, TA | 1 |
| Watt, MJ | 1 |
| Oldfield, BJ | 1 |
| Wang, W | 1 |
| Meng, X | 1 |
| Yang, C | 1 |
| Fang, D | 1 |
| Wang, X | 1 |
| An, J | 1 |
| Zhang, J | 1 |
| Wang, L | 1 |
| Lu, T | 1 |
| Ruan, HB | 1 |
| Gao, Y | 1 |
| Itoh, H | 1 |
| Buñag, RD | 1 |
| el Kadi, AO | 1 |
| Sharif, SI | 1 |
| Aoi, M | 1 |
| Date, I | 1 |
| Tomita, S | 1 |
| Ohmoto, T | 1 |
| Ben, V | 1 |
| Bruguerolle, B | 1 |
6 other studies available for oxidopamine and Weight Loss
| Article | Year |
|---|---|
Mechanisms underlying the efficacy of a rodent model of vertical sleeve gastrectomy - A focus on energy expenditure.
Topics: Animals; Body Weight; Energy Metabolism; Gastrectomy; Glucose; Humans; Male; Oxidopamine; Rats; Rats | 2023 |
Brown adipose tissue activation in a rat model of Parkinson's disease.
Topics: Adipose Tissue, Brown; Animals; Cold Temperature; Denervation; Male; Oxidopamine; Parkinson Disease, | 2017 |
Age-related reduction of reflex bradycardia in conscious rats by catecholaminergic nucleus tractus solitarius lesions.
Topics: Aging; Animals; Blood Pressure; Bradycardia; Heart Rate; Male; Medulla Oblongata; Nitroprusside; Oxi | 1993 |
The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
Topics: Animals; Behavior, Animal; Chlorpheniramine; Cimetidine; Dose-Response Relationship, Drug; Histamine | 1996 |
The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
Topics: Animals; Apomorphine; Axons; Behavior, Animal; Disease Models, Animal; Dopamine; Dopamine Agonists; | 2000 |
Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study.
Topics: Animals; Body Temperature; Corpus Striatum; Disease Models, Animal; Heart Rate; Locomotion; Male; Ox | 2000 |